Intestinal Research

IBD
Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence: Seow-Neng Chan, Eden Ngah Den Low, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar; Intest Res. 2018;16(3):374-383. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.374
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

What's app? Electronic health technology in inflammatory bowel disease: Alissa Walsh, Simon Travis; Intest Res. 2018;16(3):366-373. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.366
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

The importance of immunization in immune-mediated inflammatory disease cannot be overstated: Sang Hyoung Park; Intest Res. 2018;16(3):325-326. Published online July 27, 2018; DOI: https://doi.org/10.5217/ir.2018.16.3.325; Full text PubReader ePub Crossref - TDM PDF

The old versus the new: which do you keep in postoperative Crohn's disease?: Paulo Gustavo Kotze, Christopher Ma, Miguel Regueiro, Remo Panaccione; Intest Res. 2018;16(2):319-320. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.319
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?: Meng-Tzu Weng, Chien-Chih Tung, Jau-Min Wong, Shu-Chen Wei; Intest Res. 2018;16(2):312-314. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.312
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

A case of ulcerative colitis presenting with cerebral venous thrombosis: Junghwan Lee, Sung Wook Hwang, Jinhee Lee, Kyung Hwa Jung, Ha Il Kim, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang; Intest Res. 2018;16(2):306-311. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.306
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Intraoperative inspection alone is a reliable guide to the choice of surgical procedure for enteroenteric fistulas in Crohn's disease: Zhen Guo, Xingchen Cai, Ruiqing Liu, Jianfeng Gong, Yi Li, Lei Cao, Weiming Zhu; Intest Res. 2018;16(2):282-287. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.282; Full text PubReader ePub Crossref - TDM PDF

Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy: Daisuke Saito, Mari Hayashida, Taro Sato, Shintaro Minowa, Osamu Ikezaki, Tatsuya Mitsui, Miki Miura, Akihito Sakuraba, Tadakazu Hisamatsu; Intest Res. 2018;16(2):273-281. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.273
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea: Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee; Intest Res. 2018;16(2):267-272. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.267
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study: Haruhiko Ogata, Tadashi Yokoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi; Intest Res. 2018;16(2):255-266. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.255
Cited By 8; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies: Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi; Intest Res. 2018;16(2):233-245. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.233
Cited By 17; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study: Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh; Intest Res. 2018;16(2):223-232. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.223
Cited By 9; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis: Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee,; Intest Res. 2018;16(2):216-222. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.216
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis?: Natalie Grace Fairhurst, Simon P. L. Travis; Intest Res. 2018;16(2):209-215. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.209
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

Management of inflammatory bowel disease in older persons: evolving paradigms: Saurabh Kedia, Jimmy K. Limdi, Vineet Ahuja; Intest Res. 2018;16(2):194-208. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.194
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

IBD